The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cambay Production Update and Fund Raise

4 May 2022 07:00

RNS Number : 1880K
Oilex Ltd
04 May 2022
 

ASX-RNS Announcement

 

4 May 2022

 

ASX: OEX / AIM: OEX

Cambay Production Update and Fund Raise

 

Oilex Limited (Oilex or the Company) is pleased to announce the following update with respect to its operations in India, as well as completion of a £2.5 million fundraise.

 

Operational Update

 

After a lengthy shut-in of production on the Company's Cambay field (WI 100%), gas production and sales have been stabilised from one well (C-73) at circa 0.3 mmscfd, with circa 21 bopd of gas condensate. Current C-73 production rates (c. 0.3 mmscfd) demonstrate stable wellhead pressures. The Company plans to co-mingle production from the C-77H horizontal and fracced well while ramping up to higher sustainable production rates.

 

Fundraise

 

The Company has arranged an equity capital raising, with existing sophisticated, institutional and other shareholders, led by Republic Investment Management Pte Ltd (Republic) and clients of Novum Securities Limited (Novum), of £2.5 million (approximately AUD$4.4 million) before expenses, through the issue of 1,250,000,000 new fully paid ordinary shares (Placement Shares) at GBP 0.20 pence (AUD 0.35 cents) per share (Placement).

 

The Placement will be completed in two tranches: the first on 27 May 2022 and the second on or about 20 June 2022, subject to approval by Oilex Shareholders.

 

The Company intends to issue 1,075,168,606 Placement Shares under the Company's current ASX Listing Rule 7.1 placement capacity, with completion, as above, being targeted for 27 May 2022. The balance of 174,831,394 Placement Shares will be issued subject to shareholder approval, and a general meeting of Oilex shareholders is anticipated to be held in mid-June 2022, with completion, as above, being targeted for 20 June 2022.

 

Pursuant to the capital raising advisory agreements, the Company will also issue of 30,000,000 unquoted options, exercisable at GBP 0.20 pence (0.35 AUD cents) on or before 30 April 2024 (Fee Options). The issue of the Fee Options is subject to the shareholder approval at the aforementioned general meeting in mid-June 2022.

 

Funds raised from the Placement are intended to be applied to the re-fraccing of the Cambay 77H well scheduled for July 2022 (with such re-fraccing now fully funded), the continued development of the Company's plans to undertake a drilling and testing appraisal program on the Cambay field, and the Company's working capital base.

 

The Placement Shares will rank pari passu in all respects with the existing shares. Application will be made in due course to the London Stock Exchange for the Placement Shares to be admitted to trading on AIM with a further announcement at that time. The applicable ASX Appendix 3B is to be submitted shortly.

 

Total Voting Rights

Following the issue of all of the Placement Shares, the Company's share capital and total voting rights will comprise 8,417,790,704 shares. The Company does not hold any shares in treasury. Consequently, 8,417,790,704 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Related Party Transaction

Republic Investment Management Pte Ltd (Republic) has arranged to subscribe for £1.5 million (approximately AUD$2.64 million) of the Placement. As a result of Republic being categorised as a Substantial Shareholder of the Company, it is deemed a related party of the Company pursuant to the AIM Rules for Companies (AIM Rules). Accordingly, Republic's participation in the Placement is classified as a related party transaction pursuant to the AIM Rules.

The Directors of the Company, having consulted with Strand Hanson Limited, the Company's Nominated Adviser, consider that the terms of Republic's participation in the Placement are fair and reasonable insofar as the Company's shareholders are concerned.

 

Oilex's Chief Executive Officer, Roland Wessel, said:

 

"We are very pleased with the support of existing and new institutional shareholders in the Placing. The placing price of GBP 0.20 pence represents no discount to the current price and shows confidence that these shareholders see significant value going forward. We are now fully funded for the July re-frac of C-77H and we also look forward to increasing daily production rates."

 

For and on behalf of Oilex Ltd

 

Roland Wessel

Managing Director

For further information, please contact:

 

Investor Enquiries

Oilex Ltd

Roland Wessel

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquiries (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Finlay Thomson

Email: patrick.dancona@vigocomms.com

finlay.thomson@vigocomms.com

Tel:+ 44 20 7390 0230 UK

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUPUWAAUPPGQW
Date   Source Headline
7th Aug 20209:32 amRNSTermination of JPDA Arbitration Proceedings
31st Jul 202011:07 amRNSJune 2020 Quarterly Report
31st Jul 202010:45 amRNSLoan Restructure and Equity Issue
30th Jul 20209:00 amRNSManaging Director Contract Extension
27th Jul 20207:00 amRNSWest Kampar Update
17th Jul 20207:07 amRNSIssue of Securities
30th Jun 202010:40 amRNSSuccessful Bid for Cooper Basin Permit
30th Jun 20208:17 amRNSResults of General Meeting
30th Jun 20208:11 amRNSExecutive Director Contract Extension
30th Jun 20208:05 amRNSChange of Registered Office
29th Jun 20207:00 amRNSIndia Update
15th Jun 202010:28 amRNSChange to Notice of Meeting
15th Jun 20207:56 amRNSArmour Share Purchase Agreement
5th Jun 202011:52 amRNSExtension to Armour Agreement
3rd Jun 20201:14 pmRNSNotice of Change of Interest of Substantial Holder
1st Jun 20207:15 amRNSExtension to Armour Agreement
29th May 20207:00 amRNSNotice of General Meeting
27th May 20209:28 amRNSSale of Cooper Eromanga Basin Assets
26th May 20207:00 amRNSNotice of Change of Interest of Substantial Holder
15th May 20207:00 amRNSIssue of Securities
6th May 20207:00 amRNSAppendix 3Z B Lingo
6th May 20207:00 amRNSReplacement Appendix 5B
5th May 20208:36 amRNSBoard Changes
30th Apr 20209:16 amRNSMarch 2020 Quarterly Report
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
28th Apr 202011:02 amRNSCooper Basin Update
27th Apr 20207:14 amRNSCorrection: Variation to Financing Terms
23rd Apr 20201:45 pmRNSVariation to Financing Terms
3rd Apr 20207:00 amRNSChairman Consulting Contract Extension
3rd Apr 20207:00 amRNSExtension for Acquisition of Cooper Licences
26th Mar 20207:32 amRNSAppendix 3X Mark Bolton
26th Mar 20207:00 amRNSBoard and Executive Changes
24th Mar 20207:30 amRNSDoriemus Transaction - Update
16th Mar 20207:15 amRNSInterim Report 31 December 2019
16th Mar 20207:00 amRNSBusiness and Financial Restructure
12th Mar 20207:00 amRNSDoriemus Shareholders Approve Transaction
6th Mar 20207:15 amRNSOpportunity to Participate in Doriemus Offer
3rd Mar 202012:24 pmRNSUpdate on Cambay Sale Process
28th Feb 20209:29 amRNSExtension for Acquisition of Cooper Basin Licences
21st Feb 20207:30 amRNSStrong Funding Support for Cooper-Eromanga
11th Feb 20207:00 amRNSChairman Consulting Contract Extension
4th Feb 20207:00 amRNSAppendix 3B: Issue of Securities
3rd Feb 20202:23 pmRNSNew Series C Loan Facility
31st Jan 20208:17 amRNSDecember 2019 Quarterly Report
30th Jan 20207:00 amRNSDOR - Prop Acqn of Major Cooper-Eromanga Portfolio
29th Jan 202010:39 amRNSSale of Cooper Eromanga Basin Assets
28th Jan 20207:00 amRNSSale of Participating Interest in Bhandut
17th Jan 20202:05 pmRNSUpdate on Cambay Sale Process
7th Jan 20207:34 amRNSNotice of Change of Interest of Substantial Holder

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.